Shantha Biotechnics indigenously to develop, manufacture and market recombinant human healthcare products in India.

Shantha Biotechnics, a Hyderabad based company started in 1993 has earned revenues of Rup 1.5 bn. The company is engaged in developing, manufacture and marketing of recombinant human healthcare products. The company, for the development of generic biologicals, novel therapeutic antibodies, proteins and vaccines, conducts R&D activities. Research is also carried out in the fields of oncology, infectious diseases and platform technologies. Shantha caters to markets in Asia Pacific, …